CME
Why ICIs Have Revolutionized Cancer Care
October 31, 2022
Guest: Patrick Forde, MD Guest: Jess Garca-Foncillas, MD, PHD Immune checkpoint inhibitors, or ICIs, have improved the prognosis for patients with many different types of cancer. Drs. Forde and Garca-Foncillas outline current biomarkers and the
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!